drugset / Trial / NCT07186426

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

NCT07186426

Phase 3 Recruiting 405 enrolled Haisco Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multi-center, randomized, double-blind, placebo/active-controlled study. 405 subjects undergoing orthopedic surgery under general anesthesia are planned to be enrolled and randomized into the HSK21542 group, morphine group, and placebo group.

Timeline

Start
2025-07-28
Primary completion
2026-03-01
Completion
2026-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject HSK21542 Peptide
Comparator Morphine Other / unclassified

Indications

No indication recorded.